Canada markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
203.24-6.65 (-3.17%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
919,450
475,598
18,662
34,288
31,176
Operating Expenses
Research Development
1,322,803
747,027
113,842
173,797
168,435
Selling General and Administrative
199,101
145,290
34,417
34,409
34,451
Total Operating Expenses
1,521,904
892,317
148,259
208,206
202,886
Operating Income or Loss
-602,454
-416,719
-129,597
-173,918
-171,710
Interest Expense
16,937
15,145
12,188
12,188
14,072
Total Other Income/Expenses Net
6,938
13,605
10,515
2,782
2,013
Income Before Tax
-612,097
-418,259
-132,694
-184,748
-183,769
Income from Continuing Operations
-615,114
-418,259
-132,694
-184,748
-183,769
Net Income
-615,114
-418,259
-132,694
-184,748
-183,769
Net Income available to common shareholders
-615,114
-418,259
-132,694
-184,748
-183,769
Basic EPS
-
-7.27
-5.51
-10.00
-12.60
Diluted EPS
-
-7.27
-5.51
-10.00
-12.60
Basic Average Shares
-
57,554
24,100
18,488
14,633
Diluted Average Shares
-
57,554
24,100
18,488
14,633
EBITDA
-
-398,229
-114,830
-164,401
-159,880